Zanamivir for the Treatment of Influenza A and B Infection in High-Risk Patients
Open Access
- 22 January 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 161 (2), 212-217
- https://doi.org/10.1001/archinte.161.2.212
Abstract
Research from JAMA Internal Medicine — Zanamivir for the Treatment of Influenza A and B Infection in High-Risk Patients — A Pooled Analysis of Randomized Controlled TrialsKeywords
This publication has 17 references indexed in Scilit:
- Immune response to influenza vaccination in a large healthy elderly populationVaccine, 1998
- Effectiveness of influenza vaccine in reducing hospital admissions during the 1989–90 epidemicEpidemiology and Infection, 1997
- Use of Antivirals in Influenza in the Elderly: Prophylaxis and TherapyGerontology, 1996
- Influenza Vaccine Effectiveness in Preventing Hospitalization among the Elderly during Influenza Type A and Type B SeasonsInternational Journal of Epidemiology, 1995
- Reduction in mortality associated with influenza vaccine during 1989-90 epidemicThe Lancet, 1995
- Influenza: diagnosis, management, and prophylaxisBMJ, 1994
- Influenza Vaccine Effectiveness in Preventing Hospitalization for Pneumonia in the ElderlyAmerican Journal of Epidemiology, 1992
- Emergence and Transmission of Influenza A Viruses Resistant to Amantadine and RimantadineCurrent Topics in Microbiology and Immunology, 1992
- Influenza: Quantifying morbidity and mortalityAmerican Journal Of Medicine, 1987
- Antiviral activity of amantadine: a review of laboratory and clinical dataPharmacology & Therapeutics, 1980